Similar articles for PMID: 25106443

Year	Number of Results
1997	1
1998	2
2000	1
2001	1
2002	3
2003	2
2004	2
2005	4
2006	8
2007	3
2008	5
2009	2
2010	2
2011	2
2012	10
2013	5
2014	2
2015	1
2016	1
2017	2
2018	1
2024	0

1

High matrix metalloproteinase levels are associated with dermal graft failure in diabetic foot ulcers.

Izzo V, Meloni M, Vainieri E, Giurato L, Ruotolo V, Uccioli L. Izzo V, et al. Int J Low Extrem Wounds. 2014 Sep;13(3):191-6. doi: 10.1177/1534734614544959. Epub 2014 Aug 8. Int J Low Extrem Wounds. 2014. PMID: 25106443

2

[Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel].

He LP, Wang C, Chen DW, Li XJ, Ran XW. He LP, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Sep;43(5):757-61. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23230755 Clinical Trial. Chinese.

3

Dermal substitute template use in diabetic foot ulcers: case reports.

Alagaratnam S, Choong A, Loh A. Alagaratnam S, et al. Int J Low Extrem Wounds. 2012 Sep;11(3):161-4. doi: 10.1177/1534734612447802. Epub 2012 Jun 3. Int J Low Extrem Wounds. 2012. PMID: 22665922

4

Dermal regeneration template in the surgical management of diabetic foot ulcers: a series of five cases.

Silverstein G. Silverstein G. J Foot Ankle Surg. 2006 Jan-Feb;45(1):28-33. doi: 10.1053/j.jfas.2005.10.005. J Foot Ankle Surg. 2006. PMID: 16399556

5

Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.

Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Lobmann R, et al. Diabetologia. 2002 Jul;45(7):1011-6. doi: 10.1007/s00125-002-0868-8. Epub 2002 May 25. Diabetologia. 2002. PMID: 12136400

6

Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.

Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Lobmann R, et al. J Diabetes Complications. 2006 Sep-Oct;20(5):329-35. doi: 10.1016/j.jdiacomp.2005.08.007. J Diabetes Complications. 2006. PMID: 16949521 Clinical Trial.

7

Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.

Li Z, Guo S, Yao F, Zhang Y, Li T. Li Z, et al. J Diabetes Complications. 2013 Jul-Aug;27(4):380-2. doi: 10.1016/j.jdiacomp.2012.12.007. Epub 2013 Jan 26. J Diabetes Complications. 2013. PMID: 23357650

8

Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.

Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP. Brem H, et al. Surg Technol Int. 2003;11:23-31. Surg Technol Int. 2003. PMID: 12931279 Review.

9

Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.

Uccioli L, Giurato L, Ruotolo V, Ciavarella A, Grimaldi MS, Piaggesi A, Teobaldi I, Ricci L, Scionti L, Vermigli C, Seguro R, Mancini L, Ghirlanda G. Uccioli L, et al. Int J Low Extrem Wounds. 2011 Jun;10(2):80-5. doi: 10.1177/1534734611409371. Int J Low Extrem Wounds. 2011. PMID: 21693443 Clinical Trial.

10

DermACELL: Human Acellular Dermal Matrix Allograft A Case Report.

Cole WE. Cole WE. J Am Podiatr Med Assoc. 2016 Mar;106(2):133-7. doi: 10.7547/14-091. J Am Podiatr Med Assoc. 2016. PMID: 27031550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year